Investigation in Progress — No Complaint Filed Yet
BG&G is actively investigating potential securities fraud claims against FMC Corporation. If a complaint is filed, this page will be updated. Investors are encouraged to contact us now to preserve their rights.
Why Is FMC Corporation (FMC) Under Investigation?
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of shareholders of FMC Corporation (NYSE: FMC).
On October 15, 2026, FMC issued a press release “updat[ing] its expectations for third quarter 2026.” FMC advised that “[r]evenue is now expected to be between $65 million and $125 million with expected Adjusted EBITDA of negative $565 million to negative $510 million.” The Company said that “[t]hese estimates include an estimated $625 million to $675 million impact related to commercial actions to lower the price of select products held by channel customers in key markets and to modify the selling and pricing model in the United States.” On news of the updated guidance, which fell well short of consensus estimates, FMC’s stock price fell $2.47 per share, or 30.53%, to close at $5.62 per share on October 15, 2026.
What Potential Securities Violations Is BG&G Investigating?
- Whether FMC Corporation and certain of its officers made false or misleading statements regarding the Company's financial condition and business prospects.
- Whether FMC Corporation failed to disclose material adverse information that would have been significant to a reasonable investor.
- Whether the Company's earnings guidance was supported by a reasonable factual basis at the time it was made.
What Should FMC Corporation (FMC) Investors Do?
How Did FMC Corporation (FMC) Stock React?
How Does BG&G Help Investors in Securities Fraud Investigations?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
We handle cases on a contingency fee basis — we advance all litigation costs on your behalf. There is no fee unless we are successful.
“Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace.”